Patent · US Active

PD-1/PD-L1 inhibitors

US11555029B2 · kind B2 · utility

1Cited by
6References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 3, 2020
Grant dateJan 17, 2023
Priority date—
Expiry dateJun 3, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K16/2827
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.